CEPV's Losses Mount Pre-IPO, Secures $255.4M for SPAC Hunt

TL;DR

**CEPV is a pre-revenue SPAC burning cash, but its successful $255.4M raise gives it a two-year window to find a deal or bust.**

AI Summary

Cantor Equity Partners V, Inc. (CEPV) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $43,618, a substantial rise from the $2,880 net loss in the prior year. This was primarily driven by a surge in general and administrative costs to $43,618 from $2,880. The company's balance sheet shows total assets of $164,309 as of September 30, 2025, up from $306 at December 31, 2024, largely due to deferred offering costs. Total liabilities also increased dramatically to $209,809 from $2,188, including a new related-party note payable of $118,175. Shareholder's deficit widened to $45,500 from $1,882. CEPV completed its Initial Public Offering on November 5, 2025, raising $250,000,000, and a private placement of $5,400,000, with net proceeds of $250,000,000 placed into a Trust Account for a future business combination. The company has not yet commenced operations and is focused on identifying a target business in sectors like financial services, digital assets, or healthcare.

Why It Matters

This filing reveals CEPV's financial state just before its IPO, showing increased losses and liabilities as it prepared to go public. For investors, the successful IPO and private placement, raising a combined $255.4 million, provide the capital for its intended business combination, but the pre-IPO losses highlight the inherent risks of a SPAC with no operations. Employees and customers of potential target companies will be impacted by CEPV's strategic focus on sectors like financial services and technology. The competitive landscape for SPACs remains intense, and CEPV's ability to identify and execute a compelling acquisition by November 5, 2027, will determine its long-term viability and market impact.

Risk Assessment

Risk Level: high — The company reported a working capital deficit of approximately $210,000 as of September 30, 2025, up from $2,000 at December 31, 2024, indicating significant short-term liquidity challenges prior to the IPO. Furthermore, the accumulated deficit grew to $70,500 by September 30, 2025, from $26,882 at December 31, 2024, reflecting increasing losses without any operating revenue. The entire business model hinges on completing a business combination by November 5, 2027, with no guarantee of success.

Analyst Insight

Investors should monitor CEPV's progress in identifying and announcing a target business combination, as this is the primary driver of value for a SPAC. Given the high risk and pre-operational status, a 'wait and see' approach is prudent until a definitive acquisition target is identified and its terms are disclosed. Evaluate the proposed target's fundamentals and the deal's structure carefully before considering an investment.

Financial Highlights

debt To Equity

N/A

revenue

$0

operating Margin

N/A

total Assets

$ 164,309

total Debt

$ 209,809

net Income

$ -43,618

eps

$ -0.01

gross Margin

N/A

cash Position

$ 250,000,000

revenue Growth

N/A

Key Numbers

• $43,618 — Net loss for nine months ended Sept 30, 2025 (Increased from $2,880 in the prior year, indicating rising pre-operational expenses.)
• $250,000,000 — Gross proceeds from Initial Public Offering (Raised on November 5, 2025, for future business combination.)
• $5,400,000 — Gross proceeds from Private Placement (Raised simultaneously with IPO, also for future business combination.)
• $250,000,000 — Amount placed in Trust Account (Net proceeds from IPO and Private Placement, to be used for redemptions or business combination.)
• $164,309 — Total Assets as of Sept 30, 2025 (Increased from $306 at Dec 31, 2024, primarily due to deferred offering costs.)
• $209,809 — Total Liabilities as of Sept 30, 2025 (Increased from $2,188 at Dec 31, 2024, including a $118,175 related-party note.)
• $45,500 — Total Shareholder's Deficit as of Sept 30, 2025 (Widened from $1,882 at Dec 31, 2024, reflecting accumulated losses.)
• 25,540,000 — Class A ordinary shares outstanding (As of December 16, 2025, post-IPO.)
• 6,250,000 — Class B ordinary shares outstanding (As of December 16, 2025.)
• November 5, 2027 — Deadline for Business Combination (Two-year window from IPO to complete an acquisition.)

Key Players & Entities

• Cantor Equity Partners V, Inc. (company) — registrant
• Cantor EP Holdings V, LLC (company) — Sponsor of CEPV
• Continental Stock Transfer & Trust Company (company) — Trustee for the Trust Account
• J.P. Morgan Chase Bank, N.A. (company) — Initial holder of Trust Account funds
• CF Secured, LLC (company) — Affiliate of Sponsor, current holder of Trust Account funds
• U.S. Securities and Exchange Commission (regulator) — regulatory body
• Nasdaq Stock Market LLC (company) — exchange where Class A ordinary shares are registered

FAQ

Risk Factors

• Lack of Operating History and Business Operations [high — operational]: CEPV has not yet commenced operations and has no operating history. The company's ability to succeed depends on its ability to identify and complete a business combination. Without a target business, CEPV has no revenue or operations, and its ability to generate future revenue is entirely dependent on the success of a future business combination.
• Significant Increase in Net Loss and Shareholder's Deficit [high — financial]: For the nine months ended September 30, 2025, CEPV reported a net loss of $43,618, a substantial increase from $2,880 in the prior year. This was driven by a surge in general and administrative costs to $43,618 from $2,880. The shareholder's deficit widened to $45,500 from $1,882, indicating a deteriorating financial position pre-IPO.
• Dependence on Trust Account Funds for Business Combination [high — financial]: The majority of CEPV's capital, $250,000,000, is held in a trust account. These funds are intended for a future business combination. The company's ability to execute its strategy is directly tied to the successful deployment of these funds, and any issues with the trust account or the business combination process pose a significant risk.
• Related-Party Debt and Increased Liabilities [medium — financial]: Total liabilities increased dramatically to $209,809 as of September 30, 2025, from $2,188 at December 31, 2024. This includes a new related-party note payable of $118,175, highlighting potential conflicts of interest or non-arm's length transactions that could impact financial stability.
• Limited Timeframe for Business Combination [high — operational]: CEPV has a deadline of November 5, 2027, to complete a business combination. Failure to do so within this two-year window could result in the liquidation of the company and the return of funds to shareholders, representing a significant risk to the investment thesis.
• Target Business Identification and Integration Risk [medium — market]: CEPV is focused on identifying a target business in sectors like financial services, digital assets, or healthcare. The success of the company hinges on its ability to find a suitable target and successfully integrate it. There is no guarantee that a suitable target will be found or that the integration will be successful.

Industry Context

Cantor Equity Partners V, Inc. is a special purpose acquisition company (SPAC) operating in the blank-check company sector. Its strategy involves identifying and merging with a target business, with a stated interest in financial services, digital assets, or healthcare. This sector is characterized by high growth potential but also significant regulatory scrutiny and competitive pressures for identifying attractive acquisition targets.

Regulatory Implications

As a SPAC, CEPV is subject to SEC regulations governing public offerings, financial reporting, and the process of business combinations. The company must adhere to disclosure requirements and ensure compliance with rules related to the use of proceeds held in trust and the eventual merger. Any missteps in these areas could lead to regulatory action and investor dissatisfaction.

What Investors Should Do

1. Monitor target business identification and due diligence process.
2. Evaluate the terms and structure of the proposed business combination.
3. Assess the financial health and operational viability of the target company.
4. Understand the implications of the trust account and redemption rights.

Key Dates

• 2025-09-30: Nine Months Ended — Reporting period for significant increase in net loss and widening shareholder deficit, reflecting pre-operational expenses.
• 2025-11-03: Issuance of Class B ordinary shares — Retroactive adjustment to share count and amounts, impacting historical financial presentation.
• 2025-11-05: Initial Public Offering (IPO) completed — Raised $250,000,000, with net proceeds placed in trust for a future business combination.
• 2025-11-05: Private Placement completed — Raised $5,400,000, also for future business combination, with net proceeds contributing to the trust account.
• 2027-11-05: Deadline for Business Combination — Two-year window from IPO to identify and complete an acquisition; failure to do so may lead to liquidation.

Glossary

Deferred offering costs

Expenses incurred by a company in the process of an initial public offering (IPO) or other securities offering that are capitalized and amortized over a period of time or expensed upon completion of the offering. In this case, they significantly increased total assets. (These costs are a primary driver of the increase in total assets from $306 to $164,309 between December 31, 2024, and September 30, 2025.)

Shareholder's Deficit

Occurs when a company's total liabilities exceed its total assets, resulting in a negative net worth from the shareholders' perspective. It is the opposite of shareholder's equity. (CEPV has a shareholder's deficit of $45,500 as of September 30, 2025, which widened significantly from $1,882 at December 31, 2024, due to accumulated losses.)

Related party note payable

A loan or debt obligation between a company and its management, board members, significant shareholders, or other affiliated entities. These transactions require careful disclosure due to potential conflicts of interest. (CEPV incurred a $118,175 related-party note payable, contributing to the substantial increase in total liabilities.)

Trust Account

An account established by a special purpose acquisition company (SPAC) or similar entity to hold the proceeds from its IPO. These funds are typically used to finance a business combination or returned to shareholders if a combination is not completed. (CEPV placed $250,000,000 of its IPO and private placement proceeds into a trust account, which is central to its strategy for a future business combination.)

Class B ordinary shares

A class of shares that often carries different voting rights or other privileges compared to Class A shares. In the context of SPACs, Class B shares are typically held by founders and may have different conversion or forfeiture terms. (CEPV has Class B ordinary shares outstanding, with specific issuance dates and potential forfeiture conditions noted, impacting share count adjustments.)

Year-Over-Year Comparison

The nine months ended September 30, 2025, show a dramatic increase in net loss to $43,618 from $2,880 in the prior year, primarily due to escalating general and administrative costs. Total assets have surged from $306 to $164,309, largely driven by deferred offering costs, while total liabilities have ballooned from $2,188 to $209,809, including a new related-party note. Consequently, the shareholder's deficit has widened substantially from $1,882 to $45,500, reflecting the pre-operational expenses and financial structuring ahead of the IPO.

Key Financial Figures

• $0.0001 — d: Class A ordinary shares, par value $0.0001 per share CEPV The Nasdaq Stock Market

Filing Documents

• ea0269023-10q_cantor5.htm (10-Q) — 419KB
• ea026902301ex31-1_cantor5.htm (EX-31.1) — 12KB
• ea026902301ex31-2_cantor5.htm (EX-31.2) — 12KB
• ea026902301ex32-1_cantor5.htm (EX-32.1) — 5KB
• ea026902301ex32-2_cantor5.htm (EX-32.2) — 5KB
• 0001213900-25-122348.txt ( ) — 2742KB
• cepv-20250930.xsd (EX-101.SCH) — 22KB
• cepv-20250930_cal.xml (EX-101.CAL) — 10KB
• cepv-20250930_def.xml (EX-101.DEF) — 156KB
• cepv-20250930_lab.xml (EX-101.LAB) — 157KB
• cepv-20250930_pre.xml (EX-101.PRE) — 184KB
• ea0269023-10q_cantor5_htm.xml (XML) — 248KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION 1 Item 1.

Financial Statements

Financial Statements 1 Condensed Balance Sheets as of September 30, 2025 (Unaudited) and December 31, 2024 1 Condensed Statements of Operations for the Three Months and Nine Months Ended September 30, 2025 and 2024 (Unaudited) 2 Condensed Statements of Changes in Shareholder's Equity (Deficit) for the Three and Nine Months Ended September 30, 2025 and 2024 (Unaudited) 3 Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024 (Unaudited) 4 Notes to Unaudited Condensed Financial Statements 5 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 15 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 19 Item 4.

Controls and Procedures

Controls and Procedures 19

OTHER INFORMATION

PART II. OTHER INFORMATION 20 Item 1.

Legal Proceedings

Legal Proceedings 20 Item 1A.

Risk Factors

Risk Factors 20 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 20 Item 3. Defaults Upon Senior Securities 20 Item 4. Mine Safety Disclosures 20 Item 5. Other Information 20 Item 6. Exhibits 21

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements. CANTOR EQUITY PARTNERS V, INC. CONDENSED BALANCE SHEETS September 30, 2025 December 31, 2024 (Unaudited) Assets: Deferred offering costs $ 164,309 $ 306 Total Assets $ 164,309 $ 306 Liabilities and Shareholder's Deficit: Current Liabilities: Accrued expenses $ 91,634 $ 2,188 Note payable – related party 118,175 — Total Liabilities 209,809 2,188 Commitments and Contingencies Shareholder's Deficit: Preference shares, $ 0.0001 par value; 5,000,000 shares authorized; none issued or outstanding as of both September 30, 2025 and December 31, 2024 — — Class A ordinary shares, $ 0.0001 par value; 500,000,000 shares authorized; none issued or outstanding as of both September 30, 2025 and December 31, 2024 — — Class B ordinary shares, $ 0.0001 par value; 50,000,000 shares authorized; 6,325,000 shares issued and outstanding as of both September 30, 2025 and December 31, 2024 (1) 633 633 (2) Additional paid-in capital 24,367 24,367 Accumulated deficit ( 70,500 ) ( 26,882 ) Total Shareholder's Deficit ( 45,500 ) ( 1,882 ) Total Liabilities, Commitments and Contingencies and Shareholder's Deficit $ 164,309 $ 306 (1) Both periods include up to 825,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. The number of shares and the amounts have been retroactively adjusted to reflect the capitalization of the Company in the form of the issuance of 575,000 Class B ordinary shares on November 3, 2025 (See Note 6). (2) The number of shares and the amount have been retroactively adjusted to reflect the capitalization of the Company in the form of the issuance of 750,000 Class B ordinary shares on June 25, 2025 (See Note 6). The accompanying notes are an integral part of these unaudited condensed financial statements. 1 CANTOR EQUITY PARTNERS V, INC. CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) For the Three Months Ended

View Full Filing

View this 10-Q filing on SEC EDGAR